1921
Volume 100, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

HIV coinfection with hepatitis B virus (HBV), hepatitis C virus (HCV), and human T-cell lymphotropic viruses 1 and 2 (HTLV-1 and HTLV-2) is common because of shared transmission routes. There is no published data on the prevalence of these infections in people living with HIV in Sierra Leone. We conducted a cross-sectional study of 211 HIV-positive patients aged ≥ 18 years in Freetown, Sierra Leone, in November 2017. Plasma samples were analyzed using the chemiluminescent microparticle immunoassay (Architect System, Abbott ARCHITECT Analyzer, Abbott Park, IL. The majority were female (63.5%), with median age 36 years (interquartile range [IQR]: 32–44) and median CD4 count of 396 cells/µL (IQR: 214–534). Sixty patients (28.4%) were newly diagnosed and antiretroviral therapy (ART) naive; 151 patients (71.6%) were ART experienced. The prevalence of the hepatitis B surface antigen (HBsAg), total anti-hepatitis B core antibody, and anti-HCV was 21.7%, 82.9%, and 4.3%, respectively. No cases of HTLV-1 or HTLV-2 were detected. Male gender ( = 0.004) and CD4 < 350 cells/µL ( = 0.017) were associated with the HBsAg positive status.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-1001
2019-04-01
2020-09-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/100/6/tpmd181001.html?itemId=/content/journals/10.4269/ajtmh.18-1001&mimeType=html&fmt=ahah

References

  1. Chun HM, Carpenter RJ, Macalino GE, Crum-Cianflone NF, 2013. The role of sexually transmitted infections in HIV-1 progression: a comprehensive review of the literature. J Sex Transm Dis 2013: 176459.
    [Google Scholar]
  2. Eskild A, Magnus P, Petersen G, Sohlberg C, Jensen F, Kittelsen P, Skaug K, 1992. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 6: 571574.
    [Google Scholar]
  3. Kovacs A et al., 2010. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis 201: 823834.
    [Google Scholar]
  4. Thio CL, Seaberg EC, Skolasky R Jr., Phair J, Visscher B, Muñoz A, Thomas DL; Multicenter AIDS Cohort Study, 2002. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study. Lancet 360: 19211926.
    [Google Scholar]
  5. Beilke MA, Theall KP, O’Brien M, Clayton JL, Benjamin SM, Winsor EL, Kissinger PJ, 2004. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis 39: 256263.
    [Google Scholar]
  6. Giacomo M, Franco EG, Claudio C, Carlo C, Anna DA, Anna D, Franco F, 1995. Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression. Eur J Epidemiol 11: 527533.
    [Google Scholar]
  7. WHO, 2018. Global Hepatitis Report 2017. Geneva, Switzerland: World Health Organization.
    [Google Scholar]
  8. Gessain A, Cassar O, 2012. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3: 388.
    [Google Scholar]
  9. Murphy EL, Cassar O, Gessain A, 2015. Estimating the number of HTLV-2 infected persons in the world. Retrovirology 12: O5.
    [Google Scholar]
  10. Naggie S et al., ION-4 Investigators, 2015. Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med 373: 705713.
    [Google Scholar]
  11. UNAIDS, 2016. Country Sierra Leone 2016. Geneva, Switzerland: United Nations Joint Programme on HIV and AIDS.
    [Google Scholar]
  12. Massaquoi TA et al., 2018. Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban setting, Sierra Leone. PLoS One 13: e0201820.
    [Google Scholar]
  13. Yambasu EE, Reid A, Owiti P, Manzi M, Murray MJS, Edwin AK, 2018. Hidden dangers-prevalence of blood borne pathogens, hepatitis B, C, HIV and syphilis, among blood donors in Sierra Leone in 2016: opportunities for improvement: a retrospective, cross-sectional study. Pan Afr Med J 30: 44.
    [Google Scholar]
  14. Torlesse H, Wurie IM, Hodges M, 1997. The use of immunochromatography test cards in the diagnosis of hepatitis B surface antigen among pregnant women in West Africa. Br J Biomed Sci 54: 256259.
    [Google Scholar]
  15. Ansumana R et al., 2018. Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013. BMC Res Notes 11: 113.
    [Google Scholar]
  16. García-Tardón N, Gresnigt TM, Fofanah AB, Grobusch MP, 2017. Hepatitis B and C in Tonkolili Province, Sierra Leone. Lancet 390: 1485.
    [Google Scholar]
  17. Yendewa GA, Poveda E, Yendewa SA, Sahr F, Quiñones-Mateu ME, Salata RA, 2018. HIV/AIDS in Sierra Leone: characterizing the hidden epidemic. AIDS Rev 20: 105114.
    [Google Scholar]
  18. Antinori A et al., European Late Presenter Consensus Working Group, 2011. Late presentation of HIV infection: a consensus definition. HIV Med 12: 6164.
    [Google Scholar]
  19. WHO, 2016. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection, 2nd Edition. Geneva, Switzerland: World Health Organization.
    [Google Scholar]
  20. Noubiap JJN, Aka PV, Nanfack AJ, Agyingi LA, Ngai JN, Nyambi PN, 2015. Hepatitis B and C co-infections in some HIV-positive populations in Cameroon, west central Africa: analysis of samples collected over more than a decade. PLoS One 10: e0137375.
    [Google Scholar]
  21. Ladep NG et al., 2013. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. World J Gastroenterol 19: 16021610.
    [Google Scholar]
  22. Agyeman AA, Ofori-Asenso R, 2016. Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysis. AIDS Res Ther 13: 23.
    [Google Scholar]
  23. Maynard JE, 1990. Hepatitis B: global importance and need for control. Vaccine 8: S18S20.
    [Google Scholar]
  24. Yendewa GA, 2018. Hot news: new insights from IeDEA and COHERE on global trends in CD4 counts at ART initiation. AIDS Rev 20: 174175.
    [Google Scholar]
  25. Yendewa GA, Poveda E, Lakoh S, Yendewa SA, Sahr F, Jiba DF, Salgado-Barreira A, Salata RA, 2018. High prevalence of late-stage disease in newly diagnosed human immunodeficiency virus patients in Sierra Leone. Open Forum Infect Dis 5: ofy208.
    [Google Scholar]
  26. Hønge BL et al., 2014. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. PLoS One 9: e99971.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-1001
Loading
/content/journals/10.4269/ajtmh.18-1001
Loading

Data & Media loading...

  • Received : 22 Dec 2018
  • Accepted : 24 Feb 2019
  • Published online : 01 Apr 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error